Loading market dashboard
Waters Corporation
WATHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
FDA 510(k)-cleared BD BACTEC™ FXI Culture System now available to U.S. market, enabling broader access to confident bloodstream infection diagnostics. Achieves a 3-hour faster time to detection (~15% reduction) versus the prior-generation system, per clinical study data, enabling earlier targeted sepsis prevention.
Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows. Identifies up to 40% more lipids by LC‑MS/MS than the leading alternative benchtop high‑resolution mass spectrometer, advancing lipidomics research and disease understanding.
>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals. 50% extended upper mass range and comprehensive suite of structural tools advance the development of next-generation biotherapeutics.
Carnival has stabilized after a strong rally, with shares flat since August amid solid fundamentals and macro headwinds. Carnival reported strong Q1 2026 results: 6% revenue growth, 11% operating earnings growth, and adjusted EPS up to $0.20, despite higher share count. 85% of 2026 capacity is already sold, dividend reinstated at $0.15 per quarter, and further deleveraging is underway, though growth is slowing.
MILFORD, Mass., May 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Examine the evolution of Waters' (WAT) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Waters crushes Q1 2026 estimates as revenues surge 91.5%; newly acquired BD units top targets early, and 2026 guidance moves higher.
Conrad Industries is a small-cap shipbuilder trading at a discount to heavy equipment peers, supported by recent revenue and profitability improvements. CNRD shifted from a $27 million net loss in 2023 to a $19.9 million net profit in 2024, with adjusted operating cash flow also turning positive. Despite a declining backlog and order softness, especially in energy, management remains cautiously optimistic for 2026 due to government and infrastructure demand.
Waters Corporation (WAT) Q1 2026 Earnings Call Transcript
Lab equipment maker Waters raised its annual profit forecast on Tuesday after beating quarterly estimates, driven by robust demand for drug development tools and the strong performance of its biosciences and diagnostics unit, acquired last year.
Waters (WAT) came out with quarterly earnings of $2.7 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.25 per share a year ago.
First Quarter 2026 Highlights Total reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acquired businesses. Organic revenue grew 13% as reported and 11% in constant currency, exceeding the high end of the constant currency growth guidance range by 200 basis points – led by high-single-digit instrument growth and mid-teens chemistry growth within the Analytical Sciences Division.
Teleflex (TFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m.
Delivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3 Achieves 10x improvement in absolute molar mass and extended sizing, without compromising resolution or analytical throughput.2 Reduces sample consumption by 30-50% and solvent use by approximately 40%.3 MILFORD, Mass., April 14, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio.
Brown Lisle Cummings Inc. grew its holdings in shares of Waters Corporation (NYSE: WAT) by 138.4% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,445 shares of the medical instruments supplier's stock after purchasing an additional 2,000 shares
Waters Corporation (NYSE:WAT) shares are up on Wednesday as the company announced FDA clearance for its Onclarity HPV Self-Collection Kit, a significant step in expanding access to cervical cancer screening.
FDA-approved BD Onclarity™ HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows. At-home self-collection reduces significant barriers for unscreened or under-screened individuals who make up approximately 60% of cervical cancer cases.3 Waters is establishing partnerships to enable broader nationwide access to the Onclarity™ HPV Self-Collection Kit for patients and prescribers to reduce cervical cancer risk.
We bought four “new” holdings in the quarter. Two of the four — Blackstone and Otis — we have owned before. In IT, we exited Oracle and trimmed Broadcom. Our five-year investment in Oracle proved highly profitable as the company transitioned its business model from licensing to software-as-a-service. On the semiconductor side, we modestly reduced our position in Broadcom to fund our new investment in Taiwan Semiconductor.
Aberdeen Group plc decreased its holdings in shares of Waters Corporation (NYSE: WAT) by 3.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,863 shares of the medical instruments supplier's stock after selling 2,721 shares during the quarter. Aberdeen Group
ADB International Group (OTCMKTS:EQUR - Get Free Report) and Waters (NYSE: WAT - Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Valuation and Earnings This table compares ADB International
Waters (NYSE: WAT - Get Free Report) and Vicarious Surgical (NYSE: RBOT - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Insider and Institutional Ownership 94.0% of Waters shares are
MILFORD, Mass., March 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that it has priced an offering (the "Offering") of $3.5 billion aggregate principal amount of the following senior notes issued by its subsidiary, Augusta SpinCo Corporation ("Augusta"): $650 million aggregate principal amount of 4.321% Senior Notes due 2027 at the issue price of 100.000% of their principal amount; $600 million aggregate principal amount of 4.398% Senior Notes due 2029 at the issue price of 100.000% of their principal amount; $750 million aggregate principal amount of 4.656% Senior Notes due 2031 at the issue price of 100.000% of their principal amount; $750 million aggregate principal amount of 4.945% Senior Notes due 2033 at the issue price of 100.000% of their principal amount; and $750 million aggregate principal amount of 5.245% Senior Notes due 2036 at the issue price of 100.000% of their principal amount (collectively, the "Notes").
SEATTLE--(BUSINESS WIRE)--Redfin economists estimate annual housing inventory could increase by 6%-12% in markets where home sellers are given the flexibility to test out pricing strategies via ‘Private Exclusive' and ‘Coming Soon' listings (i.e., phased marketing) before formally putting their homes on the market. That's according to a new report from Redfin, the real estate brokerage powered by Rocket. “Every home is unique,” said Redfin Senior Economist Asad Khan. “That makes it challenging.
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
News Summary: Reduces standard testing times by 80%.1 Delivers an industry-leading 25,000 data points per second, detecting transient material behaviors previously invisible to measurement. 2 Operates with fewer calibrations and superior atmosphere and temperature control.
